BioSpace News Archive

JFL Capital Management, LLC (together with its affiliates, “JFL Capital”), the largest stockholder of Merrimack Pharmaceuticals, Inc. (“Merrimack” or the “Company”) (NASDAQ: MACK), with ownership of approximately 9.4% of the Company’s outstanding shares, announced today that it has withdrawn its solicitation in connection with the Company’s 2019 annual meeting of stockholders (the “Annual Meeting”).

nRichDX Inc. announces the launch of its RevolutionTM System, a high-yield sample prep platform.

Juanita Brooks, an intellectual property litigator and principal at Fish & Richardson’s Southern California office, was named Patent Litigator of the Year – California, at the seventh annual Life Science Awards sponsored by LMG Life Sciences.

The American Board of Medical Specialties (ABMS), a leading organization that oversees physician board certification and continuing certification in the United States, presented its 2019 Distinguished Service Award to the Continuing Board Certification: Vision for the Future Commission (Commission).

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019.

Today’s healthcare consumers want to take responsibility for managing their own health.

UroGen Pharma Ltd. (Nasdaq: URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, today presented updates on its advancing pipeline for urologic cancers and UGN-101 launch readiness at its Investor Day in New York on September 24, 2019.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), announced today that positive results from the Phase 2 CLARITY study evaluating pimavanserin as adjunctive treatment in patients with major depressive disorder (MDD) have been published online by The Journal of Clinical Psychiatry, the official journal of the American Society of Clinical Psychopharmacology (ASCP)

Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the “Company” or “Valens”), a vertically integrated provider of industry leading extraction products and services, including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab, is pleased to announce the voting results from the Company’s Annual General and Special Meeting of Shareholders

Lannett Company, Inc. (NYSE: LCI) today announced that it intends to offer, subject to market conditions and other factors, $75 million aggregate principal amount of convertible senior notes due 2026